Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 304, Issue 7, 2013, Pages

  Sanders, Catherine J ^a   Vogel, Peter ^a   McClaren, Jennifer L ^a   Bajracharya, Resha ^a   Doherty, Peter C ^a,b   Thomas, Paul G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Gas exchange; Influenza; Pneumocytes; Pulmonary

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGENATION; CELL LOSS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GAS ANALYSIS; GAS EXCHANGE; INFLUENZA; INOCULATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; METABOLIC RATE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; ANIMAL; BREATHING MECHANICS; DISEASE MODEL; EPITHELIUM CELL; INFLUENZA VIRUS A; LUNG ALVEOLUS; LUNG GAS EXCHANGE; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; INFLUENZA A VIRUS; MICE; ORTHOMYXOVIRIDAE INFECTIONS; OXYGEN CONSUMPTION; PULMONARY ALVEOLI; PULMONARY GAS EXCHANGE; RESPIRATORY MECHANICS;

MLCS; MLOWN;

EID: 84878245487     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00343.2012     Document Type: Article

References (28)

1. Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, Barra NG, Chew MV, Chan T, Al-Garawi AA, Jordana M, Ashkar AA. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 206: 167-177, 2012.
2. Bates J, Irvin C, Brusasco V, Drazen J, Fredberg J, Loring S, Eidelman D, Ludwig M, Macklem P, Martin J, Milic-Emili J, Hantos Z, Hyatt R, Lai-Fook S, Leff A, Solway J, Lutchen K, Suki B, Mitzner W, Pare P, Pride N, Sly P. The use and misuse of Penh in animal models of lung disease. Am J Respir Cell Mol Biol 31: 373-374, 2004.
3. Bruder D, Srikiatkhachorn A, Enelow RI. Cellular immunity and lung injury in respiratory virus infection. Viral Immunol 19: 147-155, 2006.
4. Chan MC, Chan RW, Yu WC, Ho CC, Chui WH, Lo CK, Yuen KM, Guan YI, Nicholls JM, Peiris JS. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir Res 10: 102, 2009.
5. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, Chan YO, Chan RW, Long HT, Poon LL, Guan Y, Peiris JS. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6: 135, 2005.
6. Frank JA, Gutierrez JA, Jones KD, Allen L, Dobbs L, Matthay MA. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 165: 242-249, 2002.
7. Guarner J, Falcon-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 40: 655-661, 2009.
8. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, Mack M, Kuziel WA, Corazza N, Brunner T, Seeger W, Lohmeyer J. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205: 3065-3077, 2008.
9. Julander JG, Hagloch J, Latimer S, Motter N, Dagley A, Barnard DL, Smee DF, Morrey JD. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. Antiviral Res 92: 228-236, 2011.
10. Koerner I, Matrosovich MN, Haller O, Staeheli P, Kochs G. Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus. J Gen Virol 93: 970-979, 2012.
11. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172: 1155-1170, 2008.
12. Kosmider B, Messier EM, Janssen WJ, Nahreini P, Wang J, Hartshorn KL, Mason RJ. Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respir Res 13: 43, 2012.
13. Mason RJ. Biology of alveolar type II cells. Respirology 11 Suppl: S12-S15, 2006.
14. McElroy MC, Kasper M. The use of alveolar epithelial type I cellselective markers to investigate lung injury and repair. Eur Respir J 24: 664-673, 2004.
15. McElroy MC, Pittet JF, Hashimoto S, Allen L, Wiener-Kronish JP, Dobbs LG. A type I cell-specific protein is a biochemical marker of epithelial injury in a rat model of pneumonia. Am J Physiol Lung Cell Mol Physiol 268: L181-L186, 1995.
16. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 335: 936-941, 2012.
17. Moskophidis D, Kioussis D. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188: 223-232, 1998.
18. Mura M, Binnie M, Han B, Li C, Andrade CF, Shiozaki A, Zhang Y, Ferrara N, Hwang D, Waddell TK, Keshavjee S, Liu M. Functions of type II pneumocyte-derived vascular endothelial growth factor in alveolar structure, acute inflammation, and vascular permeability. Am J Pathol 176: 1725-1734, 2010.
19. Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, Phoon MC, Van Rooijen N, Chow VT. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179: 199-210, 2011.
20. Ng WF, To KF, Lam WW, Ng TK, Lee KC. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1-a review. Hum Pathol 37: 381-390, 2006.
21. Sly PD, Turner DJ, Collins RA, Hantos Z. Penh is not a validated technique for measuring airway function in mice. Am J Respir Crit Care Med 172: 256, 2005.
22. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 3: 499-522, 2008.
23. Uhal BD, Flowers KM, Rannels DE. Type II pneumocyte proliferation in vitro: problems and future directions. Am J Physiol Lung Cell Mol Physiol 261: L110-L117, 1991.
24. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, Ungchusak K, Angkasekwinai S, Chokephaibulkit K, Srisook K, Vanprapar N, Auewarakul P. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis 13: 708-712, 2007.
25. Wang D, Morales JE, Calame DG, Alcorn JL, Wetsel RA. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 18: 625-634, 2010.
26. Weinheimer VK, Becher A, Tonnies M, Holland G, Knepper J, Bauer TT, Schneider P, Neudecker J, Ruckert JC, Szymanski K, Temmesfeld-Wollbrueck B, Gruber AD, Bannert N, Suttorp N, Hippenstiel S, Wolff T, Hocke AC. Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis 206: 1685-1694, 2012.
27. White MK, Baireddy V, Strayer DS. Natural protection from apoptosis by surfactant protein A in type II pneumocytes. Exp Cell Res 263: 183-192, 2001.
28. Yu WC, Chan RW, Wang J, Travanty EA, Nicholls JM, Peiris JS, Mason RJ, Chan MC. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol 85: 6844-6855, 2011.